BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18845620)

  • 1. Emerging therapies for the treatment of Helicobacter pylori infections.
    Jodlowski TZ; Lam S; Ashby CR
    Ann Pharmacother; 2008 Nov; 42(11):1621-39. PubMed ID: 18845620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment for Helicobacter pylori: current criteria].
    Vaira D; Zullo A; Ricci C; Gigliotti F; Morini S
    Recenti Prog Med; 2007 Nov; 98(11):574-82; quiz 602. PubMed ID: 18044409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Helicobacter pylori.
    Wolle K; Malfertheiner P
    Best Pract Res Clin Gastroenterol; 2007; 21(2):315-24. PubMed ID: 17382279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
    Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
    J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
    Tong JL; Ran ZH; Shen J; Xiao SD
    J Clin Pharm Ther; 2009 Feb; 34(1):41-53. PubMed ID: 19125902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori.
    Fischbach L; Evans EL
    Aliment Pharmacol Ther; 2007 Aug; 26(3):343-57. PubMed ID: 17635369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori: testing and treatment.
    Talley NJ; Li Z
    Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):71-9. PubMed ID: 19072436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Helicobacter pylori infection.
    Egan BJ; Marzio L; O'Connor H; O'Morain C
    Helicobacter; 2008 Oct; 13 Suppl 1():35-40. PubMed ID: 18783520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure.
    Page RL; Ferguson D; Cantu M
    Cardiology; 2008; 110(2):112-5. PubMed ID: 17971660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. H. pylori treatment: new wine in old bottles?
    Vakil N
    Am J Gastroenterol; 2009 Jan; 104(1):26-30. PubMed ID: 19098845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Helicobacter pylori infection 2010.
    O'Connor A; Gisbert JP; McNamara D; O'Morain C
    Helicobacter; 2010 Sep; 15 Suppl 1():46-52. PubMed ID: 21054653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for H. pylori infection: new challenges with antimicrobial resistance.
    Vakil N; Vaira D
    J Clin Gastroenterol; 2013; 47(5):383-8. PubMed ID: 23388847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
    Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
    Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pylera for the eradication of Helicobacter pylori infection.
    Saleem A; Qasim A; O'Connor HJ; O'Morain CA
    Expert Rev Anti Infect Ther; 2009 Sep; 7(7):793-9. PubMed ID: 19735221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Helicobacter pylori infection: what to do after first intent treatment failure?].
    Delchier JC
    Rev Prat; 2008 Sep; 58(13):1442-4. PubMed ID: 18924328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
    Vakil N
    Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan.
    Hung KH; Sheu BS; Chang WL; Wu HM; Liu CC; Wu JJ
    Helicobacter; 2009 Feb; 14(1):61-5. PubMed ID: 19191898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
    Wueppenhorst N; Stueger HP; Kist M; Glocker E
    J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.